Company · founded 2011
Trevi Therapeutics (United States)
New Haven, United States · trevitherapeutics.com
- Citations, last 5 years
- 195
- Works, last 5 years
- 30
- h-index
- 16
- Scientists listed
- 2
- Grants since 2016
- 3
Grants received
2025–2027 · research · R41
Nanodroplet Infused Analgesic-Wafer for Transmucosal Opioid-free Treatment of Subacute Oral Pain
Chun Wang · Trevi Therapeutics (United States) · funded by National Institutes of Health
2023–2025 · research · R41
A Novel Melanoma Vaccine Based on a Shared Neoantigen and a Liquid Polymer Platform
Matthew Stephen Block · Trevi Therapeutics (United States) · funded by National Institutes of Health
2023–2024 · research · R41
A Novel Melanoma Vaccine Based on a Shared Neoantigen and a Liquid Polymer Platform
Matthew Stephen Block · Trevi Therapeutics (United States) · funded by National Institutes of Health